Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Exercise can help prevent liver cancer
Liver cancer is the fourth most common cause of cancer death worldwide and is growing…
New precision medicine procedure targets cancer and advances treatment for both pets and humans
In a first-of-its-kind study, scientists at the University of Missouri, USA, have helped advance a…
Researchers describe possible mechanism for link between obesity and breast cancer
It is widely accepted that higher levels of body fat increase the risk of developing…
Researchers block metastasis-promoting enzyme, halt spread of breast cancer
- Findings could identify aggressive breast cancers that will respond to immunotherapy
- ABC5: Results from largest group of advanced breast cancer patients answers questions about efficacy of T-DM1 when cancer returns following treatment with pertuzumab
- High expression of apoptosis protein (Api-5) in chemoresistant triple-negative breast cancers
New research highlights gaps for young adults with bone cancer
COSA ASM: Delays in diagnosis, variations in treatment and lack of participation in clinical trials may all contribute to poorer outcomes…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.